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In the amygdala, GABAergic neurons in the intercalated medial paracapsular cluster (Imp)
have been suggested to play a key role in fear learning and extinction. These neurons
project to the central (CE) amygdaloid nucleus and to other areas within and outside the
amygdala. In addition, they give rise to local collaterals that innervate other neurons in the
Imp. Several drugs, including benzodiazepines (BZ), are allosteric modulators of GABAA
receptors. BZ has both anxiolytic and sedative actions, which are mediated through
GABAA receptors containing α2/α3 and α1 subunits, respectively. To establish whether
α1 or α2/α3 subunits are expressed at Imp cell synapses, we used paired recordings
of anatomically identified Imp neurons and high resolution immunocytochemistry in the
mouse. We observed that a selective α3 subunit agonist, TP003 (100 nM), significantly
increased the decay time constant of the unitary IPSCs. A similar effect was also
induced by zolpidem (10μM) or by diazepam (1μM). In contrast, lower doses of zolpidem
(0.1–1μM) did not significantly alter the kinetics of the unitary IPSCs. Accordingly,
immunocytochemical experiments established that the α2 and α3, but not the α1 subunits
of the GABAA receptors, were present at Imp cell synapses of the mouse amygdala.
These results define, for the first time, some of the functional GABAA receptor subunits
expressed at synapses of Imp cells. The data also provide an additional rationale to prompt
the search of GABAA receptor α3 selective ligands as improved anxiolytic drugs.
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INTRODUCTION
GABAergic cells of the amygdala participate in distinct aspects
of fear learning and memory (Ehrlich et al., 2009; Herry et al.,
2010; Pape and Pare, 2010). Amongst them intercalated medial
paracapsular (Imp) neurons, located between the basolateral (BL)
complex and the central (CE) nucleus (Millhouse, 1986; Nitecka
and Ben-Ari, 1987; McDonald and Augustine, 1993; Pare and
Smith, 1993), represent one of the key cell populations medi-
ating fear learning and extinction (Likhtik et al., 2008; Amano
et al., 2010). The Imp neurons provide feed-forward inhibition
to neurons of the CE nucleus (Royer et al., 1999, 2000; Royer
and Pare, 2002), and are under cortical control (Berretta et al.,
2005; Li et al., 2011). However, their axonal fields target not only
the CE nucleus, but also segregate within the intermediate cap-
sule or project to the ansa lenticularis, resulting in three Imp
cell types (Busti et al., 2011). Therefore, Imp neurons are likely
to influence the activity of several cell populations. When presy-
naptic Imp neurons are stimulated at physiologically relevant
frequencies (range: 0.1–10Hz), unitary inhibitory postsynaptic
currents (uIPSCs) that display short-term facilitation, short-term
depression or that remain constant during the stimulation are
detected (Geracitano et al., 2007). Since this short-term plasticity
is not cell target-specific (Geracitano et al., 2007), it should occur
in virtually all the cell types synaptically coupled to the Imp
cells.
The uIPSCs evoked by Imp neurons are mediated by GABAA
receptors (Geracitano et al., 2007). These are pentameric ligand-
gated anion channels consisting of several subunits heteroge-
neously distributed in the brain and in different subcellular
domains (Farrant and Nusser, 2005). Typically, two α subunits,
two β subunits, and one γ subunit co-assemble to form a func-
tional receptor. The subunit composition of GABAA receptors
affects ligand affinity, channel gating, and modulation, thereby
shaping the kinetics of the resulting inhibitory potentials and
their functional impact on postsynaptic neurons (Capogna and
Pearce, 2011). Notably, GABAA receptors are modulated by clin-
ically important drugs including benzodiazepines (BZ) (Farrant
and Nusser, 2005). BZs increase the affinity of the receptor for
GABA, and their broad spectrum effects include: anticonvul-
sion, sedation, anxiolysis, myorelaxation, and anterograde amne-
sia (Rudolph and Knoflach, 2011; Smith and Rudolph, 2012).
GABAA receptor subtypes containing the α2 and/or α3 sub-
units appear to mediate primarily the anxiolytic action of BZs
(Rudolph and Mohler, 2006; Whiting, 2006; Smith and Rudolph,
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2012). One of the best evidence for this involvement is the
result that a novel imidazopyridine compound, namely TP003,
with full and selective agonistic activity at α3-containing recep-
tors, reduces anxiety, without inducing sedation (Dias et al.,
2005).
In summary, the available data suggest a prominent role of Imp
cells of amygdala in fear learning, and the α2 and/or α3 subunit of
GABAA receptors appears to be a novel molecular target for anx-
iolytic drugs (Likhtik et al., 2008; Rudolph and Knoflach, 2011).
Therefore, we aimed to define whether these subunit-containing
GABAA receptors are functionally present at synapses between
Imp neurons. To address this issue, we have studied the modula-
tory actions of TP003, zolpidem and diazepam (a broad spectrum
BZ agonist) on synaptic inhibition mediated by Imp neurons, and
tested the presence of α3, α2, and α1 subunits at these synapses.
MATERIALS AND METHODS
ANIMALS
Acute coronal slices were prepared from 2 to 3 weeks-old
glutamate decarboxylase 65 (GAD65)-GFP transgenic mice
(Lopez-Bendito et al., 2004; Geracitano et al., 2007), whereas
all immunocytochemical studies were carried out using adult
male C57Bl/6N mice (25–30 g; Charles River). All proce-
dures involving animals were performed according to methods
approved by the UK Home Office or by the Austrian Animal
Experimentation Ethics Board in compliance with both the
European Convention for the Protection of Vertebrate Animals
used for Experimental and Other Scientific Purposes (ETS no.
123) and the European Communities Council Directive of 24
November 1986 (86/609/EEC). The authors further attest that all
efforts were made to minimize animal suffering and the number
of animals used.
PREPARATION OF ACUTE SLICES
Two–three-weeks-old GAD65-GFP transgenic mice were deeply
anaesthetized with isoflurane in oxygenated air and then decapi-
tated. The brain was rapidly removed and placed in semi-frozen
sucrose artificial cerebro-spinal fluid (ACSF) cutting solution
containing, (in mM) 75 sucrose, 87NaCl, 2.5 KCl, 0.5 CaCl2, 7
MgCl2, 1.25NaH2PO4, 25NaHCO3, 25 glucose, pH 7.3, and
bubbled with 95%O2, 5%CO2. Slices (330μm) were cut (Leica
VT 1000S, Leica Microsystems GmbH, Nussloch, Germany) and
transferred to a nylon mesh where they were maintained in a
chamber containing sucrose ACSF at 37◦C for 30min before
returning to room temperature (24–26◦C) for another 30min.
During this one hour time period, sucrose ACSF was substituted
with normal ACSF at a rate of 1–2ml/min.
ELECTROPHYSIOLOGY AND ANALYSIS
Acute slices were secured under a nylon mesh, submerged,
and superfused (at 1–2ml/min and at 34 ± 1◦C) with ACSF,
containing (in mM) 130NaCl, 3.5 KCl, 2.5 CaCl2, 1.5MgSO4,
1.25NaH2PO4, 24NaHCO3, 10 glucose (all from VWR
International), pH 7.4 (bubbled with 95%O2, 5%CO2), in a
2ml chamber mounted on the stage of an upright microscope
(Axioskop or Axioskop 2 FS, Zeiss, Jena, Germany). Slices
were visualized with 10×/0.3NA or 40×/0.8NA (Zeiss)
water-immersion objectives coupled with infrared and dif-
ferential interference contrast (DIC) optics linked to a video
camera (Newvicon C2400, Hamamatsu, Hamamatsu City,
Japan), and a 100W mercury vapour short-arc lamp (N HBO
103, Zeiss) connected to an epifluorescence system to visualize
the GFP-expressing neurons. Somatic whole-cell patch clamp
recordings were performed from visually identified cells using
borosilicate glass capillaries (GC120F, 1.2mm o.d., Clarke
Electromedical Instruments, Reading, UK, 4–6M), pulled on
a DMZ puller (Zeitz-instrumente GmbH, Munich, Germany)
and filled with a filtered intracellular solution consisting of (in
mM): 126K-gluconate, 4 KCl, 4Mg-ATP, 0.3Na-GTP, 10Na2-
phosphocreatine, 10 Hepes, and 0.5%w/v biocytin (all from
Sigma-Aldrich Co. Ltd., Poole, UK), osmolarity 270–280 mOsm
without biocytin, pH 7.3 with KOH. Biocytin was added to allow
post-hoc visualization of the recorded neurons. Cells were only
accepted if the initial seal resistance was greater than 1G. The
series resistance (Rs) was compensated online by 50–70% in
voltage clamp mode to reduce voltage errors, and cells were only
accepted for analysis if the initial Rs did not change by more than
25% throughout the recording period. The electrophysiological
signals were amplified (10mV/pA, EPC9/2 amplifier HEKA
Electronik, Lambrecht, Germany, PULSE™ software), filtered at
2.9 kHz, and digitized at 5 kHz. Currents/voltages were acquired
online with Pulse software (HEKA) and analyzed offline with
IGOR Pro 5 software (Wavemetrics Inc., Oregon, USA). The
peak amplitude, latency, 20–80% rise time and decay time (fitted
with a single exponential) of unitary events were analyzed with
a user-defined programme in IGOR. Data throughout the text
are presented as mean ± SEM. Non-parametric two-tailed
Wilcoxon-signed ranks test was used in pre-drug/drug compar-
ison. Non-parametric two-tailed Mann–Whitney U-test and
parametric two-tailed independent sample t-test were used to
compare the effects of zolpidem (10μM) to those of diazepam
(1μM) on uIPSCs.
HISTOLOGICAL PROCEDURES
After electrophysiological recordings, slices were sandwiched
between two filter papers (cellulose nitrate membrane filters,
0.45μm, Whatman International Ltd., Maidstone, UK) and
immersed in a fixative of 4% paraformaldehyde and∼0.2% picric
acid in phosphate buffer (PB, 0.1M, pH 7.4) for at least 24 h.
Then, slices were embedded in a block of gelatin and re-sectioned
into 50–60μm slices with a Leica VT 1000 S vibratome (Leica
Microsystems, Vienna, Austria). Sections were washed in tris-
buffered saline (TBS; 0.9%NaCl, 0.05M tris, pH 7.4) and incu-
bated overnight at 4◦C in a 1:100 solution of avidin-biotinylated
horseradish peroxidase (HRP) complex (Vector labs, Burlingame,
CA, USA) in TBS + 0.1% Triton X-100 (VWR International).
Sections were further washed in TBS and Tris buffer (TB, 0.05M,
pH 7.4) before incubation in 0.5mg/ml diaminobenzidine (DAB,
Sigma) in TB. Hydrogen peroxide (0.003%) was the electron
donor for the peroxidase reaction, which was carried out in TB.
Sections were rinsed in TB, then PB, and subsequently mounted
on gelatin-coated slides and left to air-dry overnight. Sections
were then hydrated, counterstained with 0.5% cresyl violet acetate
(Sigma), dehydrated in graded ethanol (50%, 70%, 90%, 95%,
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and 100% ×2), immersed in n-butyl acetate (Merck Sharp &
Dohme, Hertfordshire, UK) and permanently mounted on slides.
All the recorded pairs included in the study were identified as
Imp neurons because their somata and dendrites were located in
the intermediate capsule. Immunofluorescent experiments were
carried out as following. Briefly, free-floating sections were pre-
incubated for 1 h in blocking solution, composed of 20% normal
goat serum (NGS), 0.1% Triton X-100 in TBS. The sections were
then incubated in rabbit polyclonal anti-GFP (diluted 1:2500,
Molecular Probes, no. A11122), made up in TBS, 0.1% Triton X-
100, and 1% NGS for approximately 48 h (4◦C). After extensive
washes in TBS, sections were incubated overnight (4◦C) with a
donkey antirabbit Alexa 488 (1:1000, Molecular Probes). Biocytin
was visualized with streptavidin-Cy3 (1:1000; Vector). Sections
were then washed and mounted onto gelatin-coated slides in
Vectashield (Vector). Immunofluorescence was studied using a
Zeiss Axioplan 2 microscope with epifluorescence illumination.
Images were analyzed and displayed using the Openlab software
(version 5.5.0; Improvision, Coventry, UK). Brightness and con-
trast were adjusted for the whole frame and no part of a frame
was modified in any way.
IMMUNOCYTOCHEMICAL PROCEDURES
For immunocytochemical light and pre-embedding immuno-
electron microscopy experiments, six C57Bl/6N adult male mice
were deeply anaesthetized by i.p. injection of 0.15ml/mouse of
Thiopental (50mg/ml; Sandoz, Kundl, Austria) and perfused with
0.9% saline for 30 s, followed by ice-chilled fixative made up of 4%
paraformaldehyde w/v (PFA; Agar Scientific, Stansted, UK) and
15% of a saturated picric acid solution v/v in phosphate buffer
(PB 0.1M, pH 7.4) for 15min. For electron microscopy experi-
ments, glutaraldehyde was added to the fixative at a final dilution
of 0.05% v/v just before the perfusion. Brains were immediately
removed from the skull washed in 0.1M PB and sliced coro-
nally in 40μm (for light microscopy) or 70μm (for electron
microscopy) thick sections, unless otherwise specified, on a Leica
VT1000S vibratome. Sections were stored in 0.1M PB containing
0.05%NaN3 at 6◦C until immunocytochemical experiments were
performed.
PRE-EMBEDDING IMMUNOCYTOCHEMISTRY FOR ELECTRON
MICROSCOPY
Pre-embedding immunocytochemistry experiments were car-
ried out according to previously published procedures with
minor modifications (Sreepathi and Ferraguti, 2012). Briefly,
free-floating sections were washed three times in 0.1M PB, cry-
oprotected in 20% sucrose made in 0.1M PB overnight at 6◦C.
After removal of the sucrose, the sections were freeze-thawed
twice to allow antibody penetration and then incubated in 20%
NGS in TBS for 2 h at RT. After blocking, sections were exposed
for ∼72 h at 6◦C to primary antibodies (see Table 1) made up
in a solution containing 2% NGS in TBS. After three washes in
TBS, sections were incubated overnight at 6◦C with the appropri-
ate secondary antibodies (Table 1). Antigen–antibody complexes
were visualized either by HRP or by nanogold-silver-enhanced
reaction. After several washes with TBS, sections were incubated
with secondary antibodies either biotinylated (Vector) or cou-
pled to nanogold (1.4 nm; Nanoprobes Inc., Stony Brook, NY,
USA) overnight at 6◦C. Silver enhancement of the gold par-
ticles was carried out using the HQ kit (Nanoprobes) for
∼10–15min. Sections were then washed extensively in milliQ
water and then with TB. Sections processed for the HRP reac-
tion were incubated in ABC complex (diluted 1:100; Vector)
made up in TB either overnight at 6◦C or at RT for 2 h and
then washed in TB several times before the antigen/antibody
complex was visualized by means of the DAB-H2O2 reaction.
Sections were subsequently washed with 0.1M PB and treated
with 2% OsO4 in 0.1M PB for 40min at RT. After several
washes with 0.1M PB and then with milliQ water, sections were
contrasted with 1% uranyl-acetate in 50% ethanol for 30min
at RT, making sure they were protected from light. Sections
were washed with milliQ water followed by graded ethanol and
propylene oxide at RT. Sections were then quickly transferred
into weighting boats containing epoxy resin (Durcupan ACM-
Fluka, Sigma, Gillingham, UK) and kept overnight at RT. The
following day, the sections were transferred onto siliconized
slides, coverslipped with ACLAR®–film coverslips (Ted Pella, Inc.,
Redding, CA), and incubated for three days at 60◦C. Blocks
containing the Imp were cut under a stereomicroscope and re-
embedded in epoxy resin. Ultrathin sections (70 nm) were cut
using a diamond knife (Diatome, Biel, Switzerland) on an ultra-
microtome (EM UC7, Leica, Vienna, Austria), collected on cop-
per slot grids coated with pioloform (Agar, Stansted, England)
and analyzed with a transmission electron microscope (Philips
CM120).
SDS-DIGESTED FREEZE-FRACTURE REPLICA LABELING (SDS-FRL)
SDS-Freeze-Fracture Replica Labeling (FRL) was performed
according to previously published procedures with minor modifi-
cations (Kasugai et al., 2010). The brains of adult mice (C57/Bl6N
mice) were perfusion-fixed with PB (0.1M, pH 7.4) contain-
ing 1% formaldehyde, and 15% of a saturated solution of picric
acid. Blocks containing the amygdala were cut into 150μm coro-
nal sections by a Leica VT1000S Vibratome and the Imp was
dissected under a stereomicroscope using an ophthalmic knife.
Tissue blocks of the Imp were cryoprotected with 30% glycerol in
0.1M PB overnight at 4◦C, then frozen by use of a high-pressure
freezing machine (HPM 010; Bal-Tec, Balzers, Liechtenstein) and
fractured by double replica method in a freeze-etching device
(BAF 060; Bal-Tec). Fractured faces were replicated by rotary
deposition of carbon (5 nm) evaporated with an electron beam
gun positioned at a 90◦ angle, shadowed unidirectionally by
platinum-carbon (2 nm) with the gun positioned at a 60◦ angle,
followed by an additional carbon layer (15 nm) applied from a
90◦ angle. Tissue was solubilized in a solution containing 2.5%
SDS and 20% sucrose made up in 15mM Tris buffer, pH 8.3, at
80◦C on a shaking platform for 18 h. Replicas were kept in the
same solution at room temperature until processed further. On
the day of immunolabeling, replicas were washed in 25mM TBS
containing 0.05% BSA and incubated in a blocking solution con-
taining 5% BSA in 25mM TBS for 1 h. Subsequently, the replicas
were incubated in primary antibodies (see Table 1). After several
washes, the replicas were reacted overnight at room temperature
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Table 1 | List of the concentrations and combinations of primary and secondary antibodies.
Primary
antibody
Source Antigen Species Dilution Secondary antibody Dilution Reaction
μ-opioid receptor ImmunoStar; catalog
#24216; lot #607102
Synthetic peptide
corresponding to amino
acids 384–398 predicted
from cloned rat MOR1
Rabbit 1:2000 Gt anti-Rb Biotinylated
(Vector)
1:500 a
1:1000 Gt anti-Rb Immunogold
conjugate (BBI)
1:30 λ ν
α1 GABAA
receptor subunit
Kindly provided by
Prof. Shigemoto
(NIPS, Okazaki,
Japan)
Amino acidic sequence
328–382 in the
intracellular loop domain
Guinea Pig 1:200 Gt anti-Gp Biotinylated
(Vector)
1:500 b
1:100 Gt anti-Gp nanogold
(Nanoprobes)
1:100 A
Rat 1:50 Gt anti-Rt Immunogold
conjugate (BBI)
1:30 λ ν σ
α2 GABAA
receptor subunit
Kindly provided by
Prof. Sieghart
(Medical University
of Vienna, Vienna,
Austria)
Amino acidic sequence
322–357 in the
intracellular loop domain
Rabbit 1:1000 Gt anti-Rb Biotinylated
(Vector)
1:500 c
1:500 Gt anti-Rb Immunogold
conjugate (BBI)
1:30 σ τ
1:500 Gt anti-Rb nanogold
(Nanoprobes)
1:100 B
α3 GABAA
receptor subunit
Kindly provided by
Prof. Sieghart
(Medical University
of Vienna, Vienna,
Austria)
Amino acidic sequence
1–11 in the N-terminal
domain
Rabbit 1:1500 Gt anti-Rb Biotinylated
(Vector)
1:500 d
1:1000 Gt anti-Rb Biotinylated
(Vector)
1:100 C
1:750 Gt anti-Rb nanogold
(Nanoprobes)
1:100 D
β3 GABAA
receptor subunit
Kindly provided by
Prof. Shigemoto
(NIPS, Okazaki,
Japan)
Amino acidic sequence
345–408 in the
intracellular loop domain
Guinea Pig 1:50 Gt anti-Gp Immunogold
conjugate (BBI)
1:30 ν τ
Reactions performed for light microscopy are indicated by small letters, those for pre-embedding electron microscopy by capital letters, whereas symbols identify
reactions for SDS-FRL.
with a mixture of gold-coupled secondary antibodies (Table 1)
made up in 25mM TBS (1:30) and containing 5% BSA. They
were then washed, picked up on 100-line copper grids and ana-
lyzed using the same TEM imaging system (CM120 TEM,Morada
CCD camera) as described before. To test for cross reactivity of
gold-conjugated secondary antibodies in colocalization studies,
control replicas were reacted with one of the primary antibod-
ies and a mixture of secondary antibodies conjugated to different
sizes of gold and directed against different species. No non-
specific cross reactivity of gold-conjugated secondary antibodies
was observed.
CHEMICALS AND DRUGS
All drugs were superfused to the slices through the bath solu-
tion. Salts used for the patch pipette solution and ACSF were
obtained from either VWR International or Sigma. Zolpidem
(Tocris Cookson Inc, Avonmouth, UK) was initially dissolved in
dimethyl sulfoxide (DMSO) before addition to the ACSF. For
1μM zolpidem, the final concentration of DMSO in the bath
was 1:10,000–1:100,000. Drugs were superfused at the following
concentrations and duration: SR 95531 hydrobromide (gabazine,
2μM), zolpidem (100 nM, 1μM, and 10μM) for 13.7 ± 2min,
diazepam (1μM) for 12.5 ± 1.5min, TP003 (100 nM) for 14.3 ±
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0.7min. The α3 subunit selective agonist TP003 was supplied by
and used with the permission of Merck Research Laboratory (NJ,
USA).
RESULTS
ACTIONS OF ZOLPIDEM AND DIAZEPAM ON uIPSCs MEDIATED
BY IMP NEURONS OF AMYGDALA
We have performed paired recordings between visually identi-
fied Imp neurons in slices obtained from GAD65-GFP mice.
The Imp neurons were observed as clusters of densely packed
cells or as thin strands of cells present between the BL and
CE nuclei. Presynaptic action potentials resulted in uIPSCs in
neurons recorded at the holding potential (VH) = −50mv, in
approximately one out of 10 recorded pairs. An action current
was evoked in the presynaptic Imp neuron at 0.1 Hz and a uIPSC
was recorded in a postsynaptic Imp neuron. The events were
entirely mediated by GABAA receptors, since they were abol-
ished by the application of 2μM gabazine (n = 3, not shown).
The mean peak amplitude of the uIPSCs was −21.7 ± 3.9 pA,
the mean 20–80% rise time was 1.3 ± 0.09ms, and the mean
decay time constant was 15.8 ± 1.4ms (n = 16). These val-
ues are similar to the ones we previously reported for uIPSCs
evoked by Imp cells (Geracitano et al., 2007). The α1 subunit
is the most commonly expressed GABAA receptor subunit in
the brain including the amygdala (Pirker et al., 2000; Rudolph
and Knoflach, 2011). Zolpidem, an imidazopyridine BZ site lig-
and, applied at 100 nM, is a selective agonist for this subunit
(Pritchett and Seeburg, 1990). Bath application of zolpidem at
this concentration did not affect the amplitude and the kinet-
ics of the uIPSCs (p > 0.5, Figure 1, Table 2). When applied
at 1μM, zolpidem is likely to have some agonistic action on
α2 and α3 subunit-containing receptors. Applied at this con-
centration, zolpidem did not modify the peak amplitude or the
rise time of the uIPSCs, but slightly increased the decay time
constant of the events, although this effect did not reach statis-
tical significance (p > 0.05, Figure 1, Table 2). When applied at
FIGURE 1 | High, but not low, concentration of zolpidem increases the
decay time constant of Imp-mediated uIPSCs. Upper traces: whole-cell
patch clamp recording of two-synaptically coupled Imp neurons from an
acute slice of amygdala. A short (3ms) voltage step to + 20mV elicited an
action current in the presynaptic cell that evoked a uIPSC in the postsynaptic
cell. Each trace is the average of 10 consecutive sweeps (0.1 Hz), recorded
with a K-gluconate-based solution at the holding potential of −55mV. In the
experiment shown, the decay of the uIPSCs, fitted with one exponential,
was: 32ms (control), 32.4ms (zolpidem 100 nM), 38ms (zolpidem 1μM),
49ms (zolpidem 10μM). Lower graph: summary histograms of normalized
peak amplitude, 20–80% rise time and decay time constant of the
uIPSCs in control (n = 6), 100 nM (n = 6), 1μM (n = 6) and 10μM (n = 6)
zolpidem, and wash out (n = 3); ∗Refers to p < 0.05, Wilcoxon-signed ranks
test.
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Table 2 | Effects of zolpidem (100nM, 1μM, and 10μM) on uIPSCs recorded from Imp paired recordings experiments.
uIPSCs Control (n = 6) zolpidem (100nM, n = 6) zolpidem (1μM, n = 6) zolpidem (10μM, n = 6) wash (n = 3)
peak amplitude (pA) −27.1±9.5 −27.3± 9.5 −25.1±7.9 −27.5±9.0 −29.0±17.4
Rise time 1.3±0.2 1.3± 0.1 1.4±0.2 1.8±0.3∗ 1.1±0.3
Decay time (ms) 18.6±2.9 19.7± 2.6 21.0±2.8 29.3±4.4 18.2±1.8
Data are expressed as mean ± SEM; n = number of recorded pairs; two-tailed Wilcoxon-signed ranks test was used for comparison between pre- and post-zolpidem
values (∗P < 0.05).
10μM, a concentration that is likely to fully activate α2 and/or α3
subunits-containing receptors, zolpidem significantly increased
the 20–80% rise time and the decay time constant of the uIP-
SCs (p < 0.05) without affecting their peak amplitude (Figure 1,
Table 2). These results were confirmed by testing the non-specific
BZ agonist diazepam (1μM) in a limited number of experiments.
The bath application of this drug mimicked the action of high
concentration of zolpidem (p > 0.1, independent sample t-test or
p > 0.5, Mann–WhitneyU-test, for the comparison of the effects
on uIPSC kinetics induced by 1μM diazepam vs. 10μM zolpi-
dem). Specifically, diazepam increased the 20–80% rise time and
the decay time constant of the uIPSCs without altering their peak
amplitude (data not shown). On average, the uIPSC peak ampli-
tude was −22.2 ± 6.3 and −23.2 ± 4.6 pA, the 20–80% rise time
was 1.5 ± 0.2 and 2.2 ± 0.4ms, and the decay time constant was
16.3 ± 3.9 and 24.3 ± 4.2, before and during diazepam (n = 3).
ACTIONS OF TP003 ON uIPSCs MEDIATED BY IMP NEURONS OF
AMYGDALA
Next, we tested more directly the involvement of the α3 sub-
unit at Imp cell synapses by using the selective α3 agonist TP003.
Consistent with the data reported above, the application of
100 nM TP003 significantly increased the decay time constant of
the uIPSCs (p < 0.05) but did not have a significant effect neither
on the 20–80% rise time nor on the peak amplitude of the events
(p > 0.5) (Figure 2, Table 3).
EXPRESSION OF α1, α2, α3 SUBUNITS OF GABAA RECEPTOR BY
Imp NEURONS
The functional data presented above indicate the presence of the
α2 and α3 and the absence of the α1 GABAA receptor subunit
at Imp cell inhibitory synapses. Next, we have investigated the
GABAA receptor subunits expressed by Imp cells by using highly
specific antibodies. Intercalated cell masses of the amygdala are
characterized by an intense expression of μ-opioid receptors, and
we have used this labeling to selectively identify processes belong-
ing to these cells (Figure 3A). Immunocytochemistry revealed
a lack of detectable α1 immunoreactivity in the Imp, with
the notable exception of a few medium-large dendrites cours-
ing across the cluster and probably belonging to large neurons
with the soma located at the edge of the cluster (Figure 3B).
Conversely, both α2 and α3 appeared highly enriched in the Imp
(Figures 3C,D). The presence of GABAA receptors containing
α2 or α3 subunits at Imp synapses was then confirmed by pre-
embedding immunoelectron microscopy (Figure 4). To reveal the
α3 subunit, we carried out both immunoperoxidase and silver-
intensified immunogold reactions. As the α3 antibody recognized
FIGURE 2 | The α3 subunit selective agonist TP003 increases the decay
time constant of Imp-mediated uIPSCs. All experimental conditions are
as in Figure 1. Upper traces: in the case illustrated, the decay of the
uIPSCs, fitted with one exponential, increased from 14.6ms to 19.3ms
during the application of 100 nM TP003. The peak amplitude was 11.8 pA
before and 9.9 pA during TP003; the rise time was 1.3ms before and 1.1ms
during TP003. Lower graph: summary histograms of normalized peak
amplitude, 20–80% rise time and decay time constant of the uIPSCs in
control (n = 7), 100 nM TP003 (n = 7), and wash out (n = 3); ∗Refers to
p < 0.05, Wilcoxon-signed ranks test.
an extracellular epitope, the peroxidase reaction end product was
observed primarily associated with the plasma membrane of the
postsynaptic specialization of symmetric synapses (Figure 4A).
However, due to its diffusion, the presynaptic active zone and
Frontiers in Neural Circuits www.frontiersin.org May 2012 | Volume 6 | Article 32 | 6
Geracitano et al. GABAA receptors of intercalated cells
Table 3 | Effects of TP003 (100nM) on uIPSCs recorded from Imp
paired recordings experiments.
uIPSCs Control TP003
(n = 6) (100nM, n = 7) wash (n = 3)
peak amplitude −16±1.6 −14.5± 1.2 −16.4± 0.8
(pA)
Rise time 1.2±0.1 1.2± 0.1 1.3± 0.1
Decay time 13.1±0.9 16.5± 1.8∗ 16.6± 1.8
(ms)
Data are expressed as mean ± SEM; n = number of recorded pairs; two-tailed
Wilcoxon-signed ranks test was used for comparison between pre- and post-
TP003 values (∗P < 0.05).
some intracellular organelles located immediately underneath the
postsynaptic membrane appeared also labeled (Figure 4A). On
the other hand, silver-gold particles were directly observed at
the postsynaptic membrane within the main body of symmetric
synapses thus demonstrating a restricted localization of the α3
subunit to postsynaptic elements (Figure 4B). Silver-intensified
immunogold reaction for the α2 subunit revealed intense labeling
of symmetric synapses (Figures 4C,D). Conversely, no detectable
labeling for the α1 subunit could be observed (not shown). To
further demonstrate a lack of α1 subunits in Imp neurons, we
draw on the SDS-FRL technique. SDS-FRL is a highly sensi-
tive immunocytochemical method that was shown to allow the
detection of GABAA receptor subunits at the protoplasmic face
(P-face) of plasma membranes (Kasugai et al., 2010). Dendrites
of Imp neurons were identified in SDS-FRL by their expression of
μ-opioid receptors and presence of numerous spines (Figure 5A).
In double labeling experiments, the μ-opioid receptor and the
α1 subunit were revealed by 10 and 5 nm gold particle-coupled
antibodies, respectively. Whereas large gold particles identify-
ing μ-opioid receptors were densely distributed throughout the
extrasynaptic area of Imp dendrites, only a few 5 nm gold par-
ticles could be detected that were not associated with synapses
and showed a density comparable to the non-specific labeling
of the secondary antibody (Figure 5A). In a subsequent triple-
labeling experiment, we indeed showed the lack of detectable α1
subunits in GABA synapses on μ-opioid receptor-positive den-
drites (Figure 5B). GABA synapses were clearly identified by the
presence of numerous gold particles for the GABAA β3 subunit
on clusters of intramembrane particles (Figure 5B). As shown in
Figure 5C, β3 and α2 subunits coexist in the same synapse on Imp
neurons. Moreover, we demonstrate that α1 subunits are enriched
in GABA synapses on pyramidal-like neurons of the basal nucleus
of the amydgala, where they coexist with α2 subunits (Figure 5D),
thus excluding a technical limitation in their identification. The
α3 subunit could not be investigated by SDS-FRL as in our exper-
imental conditions the antibody did not give specific labeling on
replica.
DISCUSSION
Taken together, our electrophysiological and immunocytochemi-
cal data demonstrate that the α2 and α3, but not the α1, GABAA
subunits are expressed at synapses of Imp neurons of amygdala
FIGURE 3 | Immunostainings for μ-opioid receptor and GABAA
receptor subunits α1–3 in consecutive sections of the mouse
amygdala. Panels on the left show low magnification images of the
basolateral (BL) complex and intercalated cell masses, whereas the panels
on the right show a higher magnification of the Imp cluster.
(A) Immunoreactivity for μOR is particularly enriched in the intercalated cell
masses such as the Imp and In (as indicated by the arrows).
(B) Immunoreactivity for the α1 subunit is very intense in the BL complex
whereas it is undetectable in the Imp, although a few dendrites can be
observed coursing across it and probably belonging to the strongly labeled
large neurons located at the edges of the cluster. (C) The expression of the
α2 subunit appears particularly strong in both the BL complex and
intercalated cell masses, including the Imp. (D) Immunoreactivity for the α3
subunit can be observed throughout the amygdala although the intercalated
cell masses display a stronger signal compared to the BL complex and
central nucleus. Abbreviations: BA, basal nucleus of the amygdala; Imp,
medial paracapsular intercalated cluster; In, main intercalated nucleus;
μ-opioid receptor, μOR. Scale bars: left panel, 500μm; right panel, 100μm.
and underlie the reciprocal synaptic inhibition mediated by this
cell population. This conclusion relies on the selective potency
of zolpidem and TP003 as well as on the specificity of the anti-
bodies for the α subunits of the GABAA receptor. In particular,
zolpidem has a high affinity for α1-containing GABAA receptors,
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FIGURE 4 | Electron micrographs of the immunolocalization of the α2
and α3 subunits in Imp synapses. (A) A symmetric synapse (indicated by
the open arrowhead) on an Imp dendrite shows electron dense peroxidase
reaction end product for α3 enriched at the plasma membrane of the
postsynaptic specialization. Because the antibody recognizes an
extracellular epitope, also the presynaptic active zone and some
intracellular organelles located immediately underneath the postsynaptic
membrane appear labeled due to the diffusion of the HRP-immunoreaction
product. Nearby an immunonegative excitatory synapse (closed arrowhead)
made with a small spine(s) can be observed. (B) Immunometal particles
visualizing α3 subunits can be seen directly located at the postsynaptic
membrane of an inhibitory synapse in the Imp. (C and D) Numerous
immunometal particles identifying the GABAA α2 subunit can be observed
leaning on the cytoplasmic portion of the postsynaptic plasma membrane
of a symmetrical inhibitory synapse (open arrowheads) in the Imp.
Abbreviations: at, axon terminal; d, dendrite; s, spine. Scale bars:
A, 500 nm; B, 200 nm; C, 250 nm; D, 200 nm.
a 20-fold lower affinity for α2/α3-containing GABAA receptors,
and no affinity for α5-containing GABAA receptors (Pritchett and
Seeburg, 1990). The recently synthesized compound TP003 is a
selective agonist of GABAA receptor containing the α3 subunit
(Dias et al., 2005) (but see below). Our data are consistent with
previous reports showing that the α3 subunit, but not the α1
subunit, is enriched in the intercalated cell masses of the mouse
amygdala (Marowsky et al., 2004; Fritschy, 2008). Positive con-
trols in the present experiments strengthen the interpretation of
a lack or very low level of expression of the α1 subunit at Imp
synapses. Namely, zolpidem affected the decay of the uIPSCs
only when applied at micromolar concentration. Moreover, in
the immunohistochemical experiments, the same antibody for
the α1 subunit that was not detectable in medium-spiny inter-
calated neurons, produced a strong labeling in other areas of the
amygdala.
While the drugs prolonged the decay of the uIPSCs, they did
not enhance the peak amplitude of the events. At other synapses,
when zolpidem increased the decay of evoked spontaneous and
quantal (miniature) IPSCs also enhanced the amplitude of the
events (De Koninck and Mody, 1994; Perrais and Ropert, 1999;
Hajos et al., 2000; Cope et al., 2005). The degree of potentia-
tion of the IPSC amplitude depends on the degree of saturation
of the receptors during synaptic transmission (Frerking et al.,
1995). Therefore, the variability in the response to various BZ lig-
ands in different types of inhibitory synapses in some areas of the
brain has been attributed to different degrees of receptor occu-
pancy (Nusser et al., 1997; Hajos et al., 2000). Our data suggest
that the GABAA receptors present at Imp cell synapses are satu-
rated under baseline transmission. This contrasts with inhibitory
synapses in the BL nucleus, where diazepam largely enhances both
evoked and mIPSCs indicating that single quanta are not satu-
rating GABAA receptors in this part of the amygdala (Marowsky
et al., 2004). The drugs enhanced the duration, but not ampli-
tude, of the uIPSCs. At the network level, the prolongation of
individual inhibitory currents is likely to result into changes of the
power and/or frequency of rhythmic activity (Cope et al., 2005).
Our data predict that selective ligands for the α3 subunit of the
GABAA receptor could change the power and/or the frequency of
network oscillations detected in the amygdala during behavioral
challenges (Pare et al., 2002).
Experimental evidence suggests the involvement of Imp cells
in fear learning and extinction expression. Indeed, the pharma-
cological ablation of Imp cells causes a deficit in the expression
of fear extinction (Likhtik et al., 2008), and a potentiation of Imp
cells-mediated synaptic inhibition of output neurons of the CE
occurs during fear extinction (Amano et al., 2010). Consistent
with this scenario, sub-populations of Imp cells are also activated
during fear conditioning, and this generates the inhibition of the
main intercalated nucleus and of the CE (central/lateral subdi-
visions), leading to the disinhibition of CE (medial subdivision)
output neurons (Busti et al., 2011; Manko et al., 2011). Thus,
Imp neurons may represent a promising target for the pharma-
cological treatment of anxiety disorders. It is important to keep
in mind, however, that fear learning and anxiety are not the same
event, and they can be dissociated (Lissek et al., 2005). Indeed,
fear learning is a phasic, apprehensive arousal to an explicit threat,
whereas anxiety is a longer-term state elicited by more diffuse
threat cues (Davis, 1998).
It is remarkable that individual GABAA receptor subtypes
involved in anxiolytic actions appear to be different from those
involved in sedation (Smith and Rudolph, 2012). Since BZs
have sedative-hypnotic but also anxiolytic effects, two actions
that would be very useful to dissociate, understanding receptor
subtype specificity in the amygdala, could provide a rationale
for the development of non-sedating BZ anxiolytics (Rudolph
and Knoflach, 2011). Experimentally it was found that GABAA
receptors expressing the α2 subunit mediate the anxiolytic-like
action of diazepam (Low et al., 2000), whereas GABAA receptors
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FIGURE 5 | SDS-FRL images show the localization of μ-opioid (μOR)
receptor and GABAA receptor subunits α1, α2, and β3 on the P-face of
Imp dendrites. (A) Double labeling for μOR (10nm) and α1 subunit (5 nm
gold particle, indicated by red arrows) shows strong expression of μOR in
extrasynaptic areas of Imp dendrites. Only background labeling levels were
observed for the α1 subunit. Insert shows an enlarged view of a single 5 nm
immunogold particle. (B) Triple-labeling for μOR (5 nm), α1 (15 nm), and β3
(10 nm) shows the lack of detectable α1 labeling both in a GABAergic synapse
identified by concentrated immunogold particles for the β3 subunit (indicated
by red arrows) on a distinct cluster of intramembrane particles, and in the
extrasynaptic area consistent with the lack or very low density of the α1
subunit at Imp dendrites. Black arrows show immunogold particles for μOR
located in extrasynaptic areas. (C) Double labeling for α2 (5 nm) and β3
(10 nm) subunits showing their colocalization in a single GABAergic synapse
of an Imp dendrite. (D) Double-labeling for α1 (10 nm) and α2 (5 nm) showing
the colocalization of these two subunits in a GABAergic synapse of a
pyramidal cell dendrite of the basal nucleus of the amygdala. Scale bars: A,
500 nm; Insert, 250 nm; B, −500 nm; C and D, 200 nm.
expressing the α1 subunit mediate the sedative action of this drug
(Rudolph et al., 1999; McKernan et al., 2000). Furthermore, the
selective α3 ligand TP003 is anxiolytic in the rodent elevated plus-
maze and in stress-induced-hyperthermia models (Dias et al.,
2005), as well as in the primate conditioned model (Fischer et al.,
2011). It is important to note that TP003 has also been demon-
strated to have a selective efficacy at recombinant α3-containing
GABAA receptor in vitro (Dias et al., 2005), but its selectivity has
not been tested in vivo.
Using the SDS-FRL technique, we also revealed that μORs
are localized extrasynaptically in Imp neurons. Our work con-
firms the enrichment of these receptors in intercalated cell masses
(Likhtik et al., 2008; Busti et al., 2011; Pinard et al., 2012).
In conclusion, GABAA receptors containing the α2 and α3 sub-
units are enriched in synapses of the Imp of the mouse amygdala.
In contrast, GABAA receptors containing the α1 subunit were
below detection in this area of the mouse amygdala. Consistent
with this, drugs able to activate the α2/α3 subunits prolonged
the duration, but not the amplitude, of uIPSCs mediated by
Imp neurons. Our data strengthen the idea that Imp neurons
of the amygdala constitute a promising target for the pharmaco-
logical treatment of anxiety disorders, and specifically for a new
generation of anxiolytic drugs without sedative effects.
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